Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Control Trial Employing fMRI to Investigate the Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers

NCT05320991 is registered in ClinicalTrials.gov with University Hospital, Bonn as lead sponsor.

NCT NCT05320991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05320991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Control Trial Employing fMRI to Investigate the Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers
Lead sponsor
University Hospital, Bonn
Phase
Phase 4
Overall status
Completed
Start date
June 15, 2019
Completion date
September 27, 2020
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ketamine-induced psychotic disorder, social cognition, theory of mind